BRPI0413372A - composto e composições de nitrofuranos de quinazolinil halogenados, seus métodos de preparação e usos como agentes antibacterianos - Google Patents

composto e composições de nitrofuranos de quinazolinil halogenados, seus métodos de preparação e usos como agentes antibacterianos

Info

Publication number
BRPI0413372A
BRPI0413372A BRPI0413372-2A BRPI0413372A BRPI0413372A BR PI0413372 A BRPI0413372 A BR PI0413372A BR PI0413372 A BRPI0413372 A BR PI0413372A BR PI0413372 A BRPI0413372 A BR PI0413372A
Authority
BR
Brazil
Prior art keywords
hydroxy
substituted
unsubstituted
antibacterial agents
nitrofurans
Prior art date
Application number
BRPI0413372-2A
Other languages
English (en)
Portuguese (pt)
Inventor
Suzanne Chamberland
Francois Malouin
Original Assignee
Ulysses Pharmaceutical Product
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ulysses Pharmaceutical Product filed Critical Ulysses Pharmaceutical Product
Publication of BRPI0413372A publication Critical patent/BRPI0413372A/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01N—PRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
    • A01N43/00—Biocides, pest repellants or attractants, or plant growth regulators containing heterocyclic compounds
    • A01N43/48—Biocides, pest repellants or attractants, or plant growth regulators containing heterocyclic compounds having rings with two nitrogen atoms as the only ring hetero atoms
    • A01N43/54—1,3-Diazines; Hydrogenated 1,3-diazines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/02—Local antiseptics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/06—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms

Landscapes

  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Environmental Sciences (AREA)
  • Oncology (AREA)
  • Engineering & Computer Science (AREA)
  • Dentistry (AREA)
  • Pest Control & Pesticides (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • Agronomy & Crop Science (AREA)
  • Communicable Diseases (AREA)
  • Plant Pathology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
BRPI0413372-2A 2003-08-08 2004-08-06 composto e composições de nitrofuranos de quinazolinil halogenados, seus métodos de preparação e usos como agentes antibacterianos BRPI0413372A (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US49333603P 2003-08-08 2003-08-08
PCT/CA2004/001466 WO2005014585A1 (en) 2003-08-08 2004-08-06 Halogenated quinazolinyl nitrofurans as antibacterial agents

Publications (1)

Publication Number Publication Date
BRPI0413372A true BRPI0413372A (pt) 2006-10-17

Family

ID=34135234

Family Applications (1)

Application Number Title Priority Date Filing Date
BRPI0413372-2A BRPI0413372A (pt) 2003-08-08 2004-08-06 composto e composições de nitrofuranos de quinazolinil halogenados, seus métodos de preparação e usos como agentes antibacterianos

Country Status (9)

Country Link
US (1) US7410974B2 (US20040106767A1-20040603-C00005.png)
EP (1) EP1660486A4 (US20040106767A1-20040603-C00005.png)
JP (1) JP2007501809A (US20040106767A1-20040603-C00005.png)
CN (1) CN1832941A (US20040106767A1-20040603-C00005.png)
AU (1) AU2004262533A1 (US20040106767A1-20040603-C00005.png)
BR (1) BRPI0413372A (US20040106767A1-20040603-C00005.png)
CA (1) CA2534405A1 (US20040106767A1-20040603-C00005.png)
MX (1) MXPA06001552A (US20040106767A1-20040603-C00005.png)
WO (1) WO2005014585A1 (US20040106767A1-20040603-C00005.png)

Families Citing this family (33)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20010016646A1 (en) * 1998-03-20 2001-08-23 David C. Rueger Osteogenic devices and methods of use thereof for repair of endochondral bone, osteochondral and chondral defects
CA2534405A1 (en) 2003-08-08 2005-02-17 Ulysses Pharmaceutical Products Inc. Halogenated quinazolinyl nitrofurans as antibacterial agents
US20080146562A1 (en) * 2003-08-08 2008-06-19 Ulysses Pharmaceutical Products Inc., Halogenated quinazolinyl nitrofurans as antibacterial agents
AU2005287825A1 (en) * 2004-09-23 2006-03-30 Ulysses Pharmaceutical Products Inc. Carbo- and hetero-cyclic antibiotics and use thereof
WO2007101274A2 (en) * 2006-03-02 2007-09-07 The Uab Research Foundation Mycobacterial disease detection, treatment, and drug discovery
CA2661223A1 (en) * 2006-08-22 2008-02-28 Concert Pharmaceuticals Inc. 4-aminoquinazoline derivatives and methods of use thereof
US20110053964A1 (en) * 2006-08-22 2011-03-03 Roger Tung 4-aminoquinazoline derivatives and methods of use thereof
WO2008113161A1 (en) * 2007-03-19 2008-09-25 Ulysses Pharmaceutical Products Inc. Phosphate prodrugs of quinazolinyl nitrofurans, methods of obtaining, and use of same
PT2552440T (pt) 2010-03-30 2019-01-10 Helperby Therapeutics Ltd Nova combinação e uso
GB201013207D0 (en) 2010-08-05 2010-09-22 Helperby Therapeutics Ltd Novel combination
PL2600869T3 (pl) 2010-08-05 2021-04-06 Helperby Therapeutics Limited Kombinacja związku pirolochinolinowego i beta-laktamowego środka przeciwdrobnoustrojowego, mupirocyny lub chlorheksydyny
GB201015079D0 (en) 2010-09-10 2010-10-27 Helperby Therapeutics Ltd Novel use
GB201305277D0 (en) 2013-03-22 2013-05-01 Helperby Therapeutics Ltd Novel combination and use
GB201307989D0 (en) 2013-05-02 2013-06-12 Helperby Therapeutics Ltd Novel combinations and use
GB201401617D0 (en) 2014-01-30 2014-03-19 Helperby Therapeutics Ltd Novel combination and use
HUE052575T2 (hu) 2014-12-18 2021-05-28 Helperby Therapeutics Ltd Új kombináció és alkalmazás
WO2016166515A1 (en) 2015-04-11 2016-10-20 Helperby Therapeutics Limited Oral composition
GB201518969D0 (en) 2015-10-27 2015-12-09 Helperby Therapeutics Ltd Triple combination
CN106924261A (zh) * 2016-04-12 2017-07-07 郑海英 一种防治牙体牙髓感染的药物组合物
GB201610869D0 (en) 2016-06-22 2016-08-03 Helperby Therapeutics Ltd Combination
GB201612093D0 (en) 2016-07-12 2016-08-24 Helperby Therapeutics Ltd Combination
GB201616014D0 (en) 2016-09-20 2016-11-02 Helperby Therapeutics Ltd Combination
GB201616909D0 (en) 2016-10-05 2016-11-16 Helperby Therapeutics Ltd Combination
GB201703898D0 (en) 2017-03-10 2017-04-26 Helperby Therapeautics Ltd Method
GB201704620D0 (en) 2017-03-23 2017-05-10 Helperby Therapeautics Ltd Combinations
GB201709193D0 (en) 2017-06-09 2017-07-26 Helperby Therapeutics Ltd Combination
CN108690012A (zh) * 2017-06-10 2018-10-23 曹艳 一种治疗革兰氏阳性菌引起的感染的药物及其合成方法
CN107021960B (zh) * 2017-06-10 2018-07-31 上海普康药业有限公司 一种治疗恶性肿瘤的药物
GB201807046D0 (en) 2018-04-30 2018-06-13 Helperby Therapeutics Ltd Combination
GB201913068D0 (en) 2019-09-10 2019-10-23 Helperby Therapeutics Ltd Combination
GB201914847D0 (en) 2019-10-14 2019-11-27 Helperby Therapeutics Ltd Combination
GB202213753D0 (en) 2022-09-20 2022-11-02 Helperby Therapeutics Ltd Antimicrobial combinations
GB202213750D0 (en) 2022-09-20 2022-11-02 Helperby Therapeutics Ltd Antimicrobial

Family Cites Families (24)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3324122A (en) * 1964-12-14 1967-06-06 Norwich Pharma Co Series of 4-substituted-2-(5-nitro-2-furyl) quinazolines
US3542784A (en) * 1968-04-05 1970-11-24 Norwich Pharma Co 4-(hydroxyanilino)-2-(5-nitro-2-furyl)quinazolines
DE2140280A1 (de) 1970-08-12 1972-02-17 Chemische Fabrik von Heyden GmbH, 8000 München 4 Amino 2 eckige Klammer auf 2 (5 Nitro 2 furyl)vinyl eckige Klammer zu chinazolinderivate, Herstellungsver fahren dafür und Arzneimittel daraus
US3970648A (en) * 1974-09-06 1976-07-20 Diamond Shamrock Corporation 2-[2-(5-Nitro-2-furyl)vinyl]-4-(anilino)quinazolines
US3974277A (en) * 1974-09-06 1976-08-10 Diamond Shamrock Corporation 2-[2-(5-Nitro-2-furyl)vinyl]-4-(anilino)quinazolines as growth promotants and feed efficiency enhancing agents
US3973021A (en) * 1974-09-06 1976-08-03 Diamond Shamrock Corporation 2-[2-(5-Nitro-2-furyl)vinyl]-4-(phydroxyanilino)quinazoline as a bactericide
JP2657760B2 (ja) * 1992-07-15 1997-09-24 小野薬品工業株式会社 ４−アミノキナゾリン誘導体およびそれを含有する医薬品
US6148377A (en) * 1996-11-22 2000-11-14 Mangosoft Corporation Shared memory computer networks
CA2279977A1 (en) 1997-02-04 1998-08-06 John S. Kiely 4-substituted-quinoline derivatives and 4-substituted-quinoline combinatorial libraries
US5925527A (en) 1997-02-04 1999-07-20 Trega Biosciences, Inc. Tricyclic Tetrahydroquinoline derivatives and tricyclic tetrahydroquinoline combinatorial libraries
US6380204B1 (en) * 1997-02-28 2002-04-30 Pfizer Inc Atropisomers of 3-heteroaryl-4(3H)-quinazolinones for the treatment of neurodegenerative and CNS-trauma related conditions
CA2282277C (en) * 1997-02-28 2005-10-11 Pfizer Products Inc. Atropisomers of 3-aryl-4(3h)-quinazolinones and their use as ampa-receptor antagonists
US6184377B1 (en) * 1997-12-15 2001-02-06 Sepracor Inc. Compositions containing N-amino- and N-hydroxy-quinazolinones and methods for preparing libraries thereof
US6943159B1 (en) * 1998-02-18 2005-09-13 Neurosearch A/S Compounds and their use as positive AMPA receptor modulators
US20020025968A1 (en) * 1998-04-15 2002-02-28 Rifat Pamukcu Method for inhibiting neoplastic cells and related conditions by exposure to 4-aminoquinazoline derivatives
US20040131628A1 (en) * 2000-03-08 2004-07-08 Bratzler Robert L. Nucleic acids for the treatment of disorders associated with microorganisms
PT1939203E (pt) 2000-04-25 2015-02-04 Icos Corp Inibidores da isoforma delta da fosfatidil-inositol 3-quinase humana
US6667300B2 (en) * 2000-04-25 2003-12-23 Icos Corporation Inhibitors of human phosphatidylinositol 3-kinase delta
US6479499B1 (en) * 2000-06-28 2002-11-12 National Science Council 2-phenyl-4-quinazolinone compounds, 2-phenyl-4-alkoxy-quinazoline compounds and their pharmaceutical compositions
PE20021011A1 (es) * 2001-03-23 2003-02-01 Bayer Corp Derivados quinazolinicos como inhibidores de la rho-quinasa
US7645878B2 (en) * 2002-03-22 2010-01-12 Bayer Healthcare Llc Process for preparing quinazoline Rho-kinase inhibitors and intermediates thereof
MXPA04010539A (es) 2002-04-26 2005-01-25 Nippon Shinyaku Co Ltd Derivados de quinazolina y medicamentos que los contienen.
AU2003265264A1 (en) 2002-07-09 2004-01-23 Point Therapeutics, Inc. Methods and compositions relating to isoleucine boroproline compounds
CA2534405A1 (en) 2003-08-08 2005-02-17 Ulysses Pharmaceutical Products Inc. Halogenated quinazolinyl nitrofurans as antibacterial agents

Also Published As

Publication number Publication date
EP1660486A1 (en) 2006-05-31
US20060258693A1 (en) 2006-11-16
CA2534405A1 (en) 2005-02-17
WO2005014585A1 (en) 2005-02-17
US7410974B2 (en) 2008-08-12
EP1660486A4 (en) 2006-12-13
AU2004262533A1 (en) 2005-02-17
JP2007501809A (ja) 2007-02-01
WO2005014585A8 (en) 2005-09-09
MXPA06001552A (es) 2006-09-04
CN1832941A (zh) 2006-09-13

Similar Documents

Publication Publication Date Title
BRPI0413372A (pt) composto e composições de nitrofuranos de quinazolinil halogenados, seus métodos de preparação e usos como agentes antibacterianos
TW200630378A (en) Macrolones-amino substituted quinolones
PA8524501A1 (es) Antibioticos macrolidos
BRPI0618374A2 (pt) uso de um composto ou um derivado do mesmo farmaceuticamente aceitável, métodos para matar microorganismos clinicamente latentes em um mamìfero, para tratar ou prevenir uma infecção microbiana em um mamìfero, para esterilizar um objeto, para preservar um material inorgánico ou orgánico, para tratar uma doença, para reduzir a dose de agente antimicrobiano convencional requerida para tratar uma infecção microbiana e para tratar uma doença de protozoário em um mamìfero, produto combinado, formulação, uso de um produto combinado, composto, e, processo para a preparação do mesmo
BRPI0307267B8 (pt) uso de compostos inibidores de beta-lactamases e composições farmacêuticas para terapia antibacteriana
BR0116216A (pt) Inibidores de girase e seus usos
BR112013025275A2 (pt) derivados de cefalosporina e suas composições farmacêuticas
BR0016605A (pt) Oxazolidinonas possuindo uma funcionalidade sulfoximina e seus usos como agente antimicrobiano
PA8451801A1 (es) Derivados de la 9-oxima eritromicina
HRP20050517B1 (hr) N-sulfonil-4-metilenamino-3-hidroksi-2-piridoni kao antimikrobni lijekovi
NZ600912A (en) Topical use of hydroxytyrosol and derivatives for the prevention of hiv infection
AP2003002942A0 (en) New derivatives of oxazolidinones as bacterial agents
TR200001330T2 (tr) Oksazolidinon türevleri ve farmasötik terkipler
BR0114763A (pt) Cetolìdeos antibacterianos
BR112022012020A2 (pt) Novos compostos e seu uso
DK1132392T3 (da) Ketolid-antibiotika
MY156304A (en) 5-hydroxymethyl-oxazolidin-2-one derivatives for treating bacterial intestinal diseases
WO2009116044A3 (en) Guanine nucleotide derivatives for treating bacterial infections
BR0313725A (pt) derivados de lincomicina que possuem atividade antibacteriana
AR039727A1 (es) Difluorotioacetamidas de oxazolidinonas como agentes antibacterianos y composicion farmaceutica en base a ellas
ES2108149T3 (es) Derivado de cefalosporina.
EA200970570A1 (ru) Макролидные соединения, обладающие противовоспалительной активностью
DE60104240D1 (de) Makrolid-Antibiotika
WO2002018353A3 (en) Oxazolidinone chemotherapeutic agents
BRPI0515564A (pt) antibióticos carbo e heterocìclicos e uso dos mesmos

Legal Events

Date Code Title Description
B08F Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette]

Free format text: REFERENTE 6A. E 7A. ANUIDADE(S).

B08K Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette]

Free format text: NAO APRESENTADA A GUIA DE CUMPRIMENTO DE EXIGENCIA. REFERENTE AS 6A E 7A ANUIDADES.